Economic Burden of Adult Patients with Moderate to Severe Atopic Dermatitis Indicated for Systemic Treatment

Economic Burden of Adult Patients with Moderate to Severe Atopic Dermatitis Indicated for Systemic Treatment

Given the introduction of new therapies targeting specific immune pathways for atopic dermatitis (AD), information on the economic burden of AD patients is needed. Direct costs (medication use and healthcare resource utilization) and costs of productivity loss were studied in 90 adult patients with...

Full description

Bibliographic Details
Main Authors: Lieneke F.M. Ariëns, Kirsten J.M. van Nimwegen, Marjan Shams, Digna T. de Bruin, Jorien van der Schaft, Harmieke van Os-Medendorp, Marjolein De Bruin-Weller
Format: Article
Language:English
Published: Society for Publication of Acta Dermato-Venereologica 2019-06-01
Series:Acta Dermato-Venereologica
Subjects:
atopic dermatitis
systemic treatment
health economics
Online Access: https://www.medicaljournals.se/acta/content/html/10.2340/00015555-3212

Internet

https://www.medicaljournals.se/acta/content/html/10.2340/00015555-3212

Similar Items